Profile
Name
Range Cancer Therapeutics Index ETFAssets under management
$13 millionExpense ratio
0.79%Asset class
EquityDomicile
USInception date
October 14, 2015Net asset value
14K USDWebsite
-Last ex-dividend date
December 29, 2021Next ex-dividend date
N/ATop holdings
Name
Weight
3.59 %
3.54 %
3.47 %
3.45 %
3.42 %
3.42 %
3.39 %
3.39 %
3.39 %
3.37 %
3.37 %
3.37 %
3.36 %
3.33 %
3.33 %
3.32 %
3.30 %
3.29 %
3.29 %
3.29 %
3.28 %
3.28 %
3.25 %
3.23 %
3.23 %
3.21 %
3.20 %
3.19 %
3.17 %
3.12 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Top holdings
Name
Weight
3.59 %
3.54 %
3.47 %
3.45 %
3.42 %
3.42 %
3.39 %
3.39 %
3.39 %
3.37 %
3.37 %
3.37 %
3.36 %
3.33 %
3.33 %
3.32 %
3.30 %
3.29 %
3.29 %
3.29 %
3.28 %
3.28 %
3.25 %
3.23 %
3.23 %
3.21 %
3.20 %
3.19 %
3.17 %
3.12 %
Analyst ratings
FAQ
- Does CNCR pay dividends?
- What stocks are in CNCR?
- What is the current assets under management for CNCR?
- What is CNCR average volume?
- What is CNCR expense ratio?
- What is CNCR inception date?
Does CNCR pay dividends?
Yes, the Range Cancer Therapeutics Index ETF does pays dividends, with
the most recent payment being
$1.85
per share. The last ex-dividend date was on December 29, 2021, and the next ex-dividend date has not been announced yet
What stocks are in CNCR?
As of today, Range Cancer Therapeutics Index ETF inlcudes 31 holdings, with 28 of them being companies from 8 different countries and 1 sectors. The most weighted holdings are Instil Bio (3.59%), Replimune (3.54%) and Iovance Biotherapeutics (3.47%)
What is the current assets under management for CNCR?
Assets under management of Range Cancer Therapeutics Index ETF is $13M
What is CNCR average volume?
Average volume of Range Cancer Therapeutics Index ETF is $7482
What is CNCR expense ratio?
Expense ratio of Range Cancer Therapeutics Index ETF is 0.79%
What is CNCR inception date?
Inception date of Range Cancer Therapeutics Index ETF is October 14, 2015